Catalyst
Slingshot members are tracking this event:
VBL Therapeutics (VBLT) Announces Overall Survival Data for VB-111 Monotherapy in Phase 2 Study for Recurrent Thyroid Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
VBLT |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 29, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Recurrent Thyroid Cancer, Vb-111 Monotherapy